| 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers (NCT04464200) | Memorial Sloan Kettering Cancer Center | 2020-07-06 |
| UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep (NCT02722668) | Masonic Cancer Center, University of Minnesota | 2017-05-15 |
| Allo HSCT Using RIC for Hematological Diseases (NCT02661035) | Masonic Cancer Center, University of Minnesota | 2017-03-09 |
| Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases (NCT01962636) | Masonic Cancer Center, University of Minnesota | 2016-12-01 |
| Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) (NCT02669017) | ADC Therapeutics S.A. | 2016-03-01 |
| Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases (NCT02145039) | Masonic Cancer Center, University of Minnesota | 2014-10-01 |
| T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies (NCT01163201) | Masonic Cancer Center, University of Minnesota | 2014-01-01 |
| Treatment for Advanced B-Cell Lymphoma (NCT01859819) | New York Medical College | 2013-01-01 |
| Double Cord Versus Haploidentical (BMT CTN 1101) (NCT01597778) | Medical College of Wisconsin | 2012-06-01 |
| Safety and Tolerability of HSC835 in Patients With Hematological Malignancies (NCT01474681) | Novartis Pharmaceuticals | 2012-01-09 |
| Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma (NCT01516593) | Andres J. M. Ferreri | 2011-11-01 |
| MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine (NCT01397825) | Millennium Pharmaceuticals, Inc. | 2011-08-09 |
| Imexon for Relapsed Follicular and Aggressive Lymphomas (NCT01314014) | University of Rochester | 2011-05-01 |
| Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients (NCT00949741) | Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie | 2009-07-01 |
| Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma (NCT00807495) | Millennium Pharmaceuticals, Inc. | 2009-02-10 |
| Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies (NCT00776373) | Abramson Cancer Center at Penn Medicine | 2007-01-01 |
| Rituximab Combined With Chemotherapy in Burkitt's Lymphoma (NCT00388193) | PETHEMA Foundation | 2006-08-01 |
| Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients (NCT00412243) | M.D. Anderson Cancer Center | 2006-03-01 |
| Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma (NCT00669877) | M.D. Anderson Cancer Center | 2002-08-01 |
| Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults (NCT00199082) | Nicola Goekbuget | 2002-07-01 |